Awards/COOPERATIVE AGREEMENT (B)

$472,859,869

Department of Health and Human Services·Centers for Disease Control and Prevention

ACTION DATE2026-04-06·SOURCEUSASPENDING·SOURCE IDASST_NON_NU50CK000556_075

Award description

CK19-1904 EPIDEMIOLOGY AND LABORATORY CAPACITY FOR PREVENTION AND CONTROL OF EMERGING INFECTIOUS DISEASES (ELC)

Verbatim from USAspending.gov. Capitalization, abbreviations, and codes are unchanged.

The Buildout's read

What the model surfaced from this award

Confidence: high

In plain English

Funds epidemiology and laboratory capacity for detecting and controlling emerging infectious diseases in Chicago.

Sub-sectors

infectious-disease-surveillancepublic-health-infrastructureepidemiology

Why this matters

Strengthens U.S. disease surveillance and response infrastructure critical for pandemic preparedness and public health security.

Supply-chain signal

Increases demand for diagnostic equipment, laboratory reagents, and epidemiological data systems from biotech suppliers.

U.S.–China competition angle

Demonstrates U.S. investment in domestic disease surveillance capabilities amid global health security competition.

Generated by award_classification v1.0.0 via claude-haiku-4-5-20251001 on 2026-05-14. Cost: $0.001315.

Period of performance

Start

2019-08-01

End

2027-07-31

Status

activein 442 days

Sources

Award record ingested from usaspending. Source identifier ASST_NON_NU50CK000556_075.

The Buildout does not edit federal records. Any inaccuracy reflects the upstream source; it will update here when corrected there.